Controverse sur le traitement initial de la maladie de parkinson : L-dopa ou agonistes dopaminergiques ?
Identifieur interne : 003E72 ( Main/Exploration ); précédent : 003E71; suivant : 003E73Controverse sur le traitement initial de la maladie de parkinson : L-dopa ou agonistes dopaminergiques ?
Auteurs : G. L. Defer [France]Source :
- Revue neurologique : (Paris) [ 0035-3787 ] ; 1999.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Homme.
English descriptors
- KwdEn :
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 001525
- to stream PascalFrancis, to step Curation: 001B20
- to stream PascalFrancis, to step Checkpoint: 001282
- to stream Main, to step Merge: 004596
- to stream Main, to step Curation: 003E72
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="fr" level="a">Controverse sur le traitement initial de la maladie de parkinson : L-dopa ou agonistes dopaminergiques ?</title><author><name sortKey="Defer, G L" sort="Defer, G L" uniqKey="Defer G" first="G. L." last="Defer">G. L. Defer</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Service de Neurologie Déjerine, CHU de la Côte de Nacre</s1><s2>14000 Caen</s2><s3>FRA</s3><sZ>1 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region" nuts="2">Région Normandie</region><region type="old region" nuts="2">Basse-Normandie</region><settlement type="city">Caen</settlement></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">99-0152819</idno><date when="1999">1999</date><idno type="stanalyst">PASCAL 99-0152819 INIST</idno><idno type="RBID">Pascal:99-0152819</idno><idno type="wicri:Area/PascalFrancis/Corpus">001525</idno><idno type="wicri:Area/PascalFrancis/Curation">001B20</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">001282</idno><idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">001282</idno><idno type="wicri:doubleKey">0035-3787:1999:Defer G:controverse:sur:le</idno><idno type="wicri:Area/Main/Merge">004596</idno><idno type="wicri:Area/Main/Curation">003E72</idno><idno type="wicri:Area/Main/Exploration">003E72</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="fr" level="a">Controverse sur le traitement initial de la maladie de parkinson : L-dopa ou agonistes dopaminergiques ?</title><author><name sortKey="Defer, G L" sort="Defer, G L" uniqKey="Defer G" first="G. L." last="Defer">G. L. Defer</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Service de Neurologie Déjerine, CHU de la Côte de Nacre</s1><s2>14000 Caen</s2><s3>FRA</s3><sZ>1 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region" nuts="2">Région Normandie</region><region type="old region" nuts="2">Basse-Normandie</region><settlement type="city">Caen</settlement></placeName></affiliation></author></analytic><series><title level="j" type="main">Revue neurologique : (Paris)</title><title level="j" type="abbreviated">Rev. neurol. : (Paris)</title><idno type="ISSN">0035-3787</idno><imprint><date when="1999">1999</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Revue neurologique : (Paris)</title><title level="j" type="abbreviated">Rev. neurol. : (Paris)</title><idno type="ISSN">0035-3787</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Agonist</term><term>Antiparkinson agent</term><term>Chemotherapy</term><term>Comparative study</term><term>Dopamine agonist</term><term>Dopamine receptor</term><term>Early phase</term><term>Human</term><term>Indication</term><term>Levodopa</term><term>Parkinson disease</term><term>Treatment</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term><term>Phase initiale</term><term>Lévodopa</term><term>Chimiothérapie</term><term>Antiparkinsonien</term><term>Agoniste</term><term>Récepteur dopaminergique</term><term>Stimulant dopaminergique</term><term>Traitement</term><term>Indication</term><term>Etude comparative</term><term>Homme</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term></keywords></textClass></profileDesc></teiHeader></TEI><affiliations><list><country><li>France</li></country><region><li>Basse-Normandie</li><li>Région Normandie</li></region><settlement><li>Caen</li></settlement></list><tree><country name="France"><region name="Région Normandie"><name sortKey="Defer, G L" sort="Defer, G L" uniqKey="Defer G" first="G. L." last="Defer">G. L. Defer</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003E72 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003E72 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= Pascal:99-0152819
|texte= Controverse sur le traitement initial de la maladie de parkinson : L-dopa ou agonistes dopaminergiques ?
}}
| This area was generated with Dilib version V0.6.29. |  |